AstraZeneca agrees to make Covid-19 vaccine for Europe

WorldNews

Published

Pharmaceutical giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing capacity continue at pace. The alliance, which was forged by Germany, France, Italy and the Netherlands to speed up production of a vaccine, is set to take...

Full Article